Sale!

Tirzepatide

Price range: $30.00 through $175.00


Synthetic research compound for advanced laboratory studies. For research use only.

QUANTITY — BUY MORE, SAVE MORE
✓
1 VIAL
$0
SINGLE
SAVE 10%
✓
2 VIALS
$0 $0
BUNDLE
SAVE 18%
✓
3 VIALS
$0 $0
POPULAR
SAVE 25%
✓
5 VIALS
$0 $0
PRO PACK
SAVE 28%
✓
10 VIALS
$0 $0
BEST VALUE
⚠️
RESEARCH USE ONLY: For laboratory research and analytical testing only. Not for human or animal consumption.
SKU: N/A Category:

Description

LATEST
HPLC / LC-MS
THIRD-PARTY
99.8%+
PURITY RANGE (HPLC-UV)
✓ Identity Confirmed: Tirzepatide (GLP TZ)

10 mg (12.38 mg)

Purity: 99.89% • Lot: Black Cap

COA PDF

15 mg (15.73 mg)

Purity: 99.79% • Lot: Pink Cap

COA PDF

20 mg (22.65 mg)

Purity: 99.80% • Lot: Light Blue Cap

COA PDF

30 mg (31.47 mg)

Purity: 99.99% • Lot: Clear Pink Cap

COA PDF

60 mg (63.99 mg)

Purity: 99.89% • Lot: Clear Cap

COA PDF

100 mg (114.45 mg)

Purity: 99.95% • Lot: Standard

COA PDF

Technical Monograph: Tirzepatide (Dual GIP & GLP-1 Receptor Co-Agonist)

Product Code: HRL-GLP-TZ | Lyophilized Polypeptide Solid

Tirzepatide is a synthetic 39-amino-acid unimolecular linear peptide engineered to act as a dual agonist at both the Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. Modified with an engineered C20 fatty diacid moiety attached via a hydrophilic linker at position 20 (Lys), Tirzepatide demonstrates calibrated dual receptor binding profiles designed for comparative incretin kinetics, beta-cell signaling cascades, and metabolic homeostatic modeling.

Core Specifications

Attribute Technical Specification
Target Mechanism Dual Co-Agonist: GIP & GLP-1 Receptors
Sequence Length 39 Amino Acids (with C20 diacid acylation)
Molecular Formula C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight 4813.45 g/mol
CAS Number 2023788-19-2
Validated Purity ≥ 99.8% via HPLC-UV
Physical Appearance White lyophilized crystalline solid

Primary Laboratory Research Domains

  • Dual Incretin Synergism: Mapping cAMP accumulation and downstream protein kinase A (PKA) pathways in cell assays co-expressing human GIPR and GLP-1R.
  • Pancreatic Islet Dynamics: In vitro observation of glucose-dependent insulin secretion (GSIS) and glucagon counter-regulatory kinetics under physiological glucose gradients.
  • Lipid Metabolism & Adipocyte Signaling: Investigating cellular lipid partitioning, adipogenesis markers, and lipoprotein lipase (LPL) regulation in primary adipocyte cultures.

Storage & Handling Guidelines

  • Lyophilized State: Store intact vials at -20°C for optimal baseline preservation. The compound exhibits chemical stability at room temperature during standard analytical shipping.
  • Reconstitution: Dissolve using laboratory-grade bacteriostatic water (0.83%–0.9% benzyl alcohol) or sterile 0.9% NaCl solution. Store reconstituted aliquots at 2°C to 8°C; do not subject to excessive mechanical agitation.

IMPORTANT NOTICE & DISCLAIMER

FOR LABORATORY RESEARCH USE ONLY. This product is a synthesized chemical reagent intended exclusively for in vitro research, analytical validation, and preclinical laboratory characterization. It is NOT a pharmaceutical drug, cosmetic, food additive, or dietary supplement, and it is NOT intended for human or animal consumption, subcutaneous administration, therapeutic use, or clinical diagnosis.

Any use outside of a regulated scientific facility is strictly prohibited. The purchasing institution or researcher assumes full regulatory compliance, handling responsibility, and safety accountability. Hudson Research Lab does not provide clinical guidance, therapeutic dosing, or medical instructions. Keep securely stored and out of reach of children.

Additional information

Strength mg

10 mg, 15 mg, 20 mg, 30 mg, 60 mg, 100 mg